简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-03-04 09:29 Hologic Partners With the WTA Tour in Landmark Title Sponsorship
2022-03-03 14:40 Publication of provisional interim result for Vifor Pharma tender offer: Participation rate of 74 percent
2022-03-01 18:27 Oral-B® Brings a New Reality to Oral Care With Ground-breaking AI Integrated Device at Mobile World Congress 2022
2022-03-01 09:32 Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients
2022-03-01 09:24 FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®
2022-02-28 19:20 Glucophage® Is the First Oral Diabetes Treatment Approved in Europe for Use During Pregnancy
2022-02-28 14:13 Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodialysis patients
2022-02-28 11:20 GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer’s Disease
2022-02-25 19:56 rf IDEAS Announces Partnership with ID R&D to Add Market-Leading Biometric Solutions to its Offering
2022-02-25 09:17 New MAVENCLAD® Data at ACTRIMS Forum 2022 Show Favourable Efficacy Outcomes Versus Other Oral DMTs and Lower Occurrence of Further Relapses or Disability Progression
2022-02-23 19:32 rf IDEAS and Key Partners to Spotlight Healthcare IAM Solutions at HIMSS22
2022-02-23 18:43 Frazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to Team
2022-02-23 15:25 Exscientia to Present at Upcoming Investor Conferences in March
2022-02-23 09:25 Taro to Acquire Alchemee From Galderma
2022-02-22 19:01 Kaneka Eurogentec Announces the Successful Production of 25g of mRNA in One Batch
2022-02-22 09:42 FINEOS Announces Strong Adoption in 2021 of Updated Purpose-Built FINEOS Platform Among Tier-1&2 Employee Benefits Insurance Carrier Clients
2022-02-21 20:11 Karen L. Ling joins Galderma’s Advisory Committee
2022-02-21 15:37 Prestige BioPharma’s Herceptin Biosimilar, Tuznue®, Receives EU-GMP Certification
2022-02-21 14:16 Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial
2022-02-21 09:17 European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

Business Wire Weibo

Press Releases

Latest Releases